Intelligent Medical Devices, Inc. - Strategic SWOT Analysis
- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Business description – A detailed description of the company’s operations and business divisions.
Corporate strategy – GlobalData’s summarization of the company’s business strategy.
SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history – Progression of key events associated with the company.
Major products and services – A list of major products, services and brands of the company.
Key competitors – A list of key competitors to the company.
Key employees – A list of the key executives of the company.
Executive biographies – A brief summary of the executives’ employment history.
Key operational heads – A list of personnel heading key departments/functions.
Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities – A list of key manufacturing facilities of the company.
Intelligent Medical Devices, Inc. (IMDx) dba IntelligentMDx designs, develops and manufactures molecular diagnostic test solutions. It has expertise in evolutionary biology, bioinformatics, microbiology, chemistry and molecular biology areas. The company’s key products are IMDx C. difficile assay, Qiagen artus C. difficile QS-RGQ MDx kit, IMDx Flu A/B and RSV for Abbott m2000 assay and IMDx VanR assay. IMDx develops its products based on NGENix platform which comprise three n silico steps: Pre-MD, Pri-MD, and Post-MD. IMDx’s pipeline product portfolio consists of DNA and RNA tests for real-time PCR and single-test and multi-test diagnostic solutions for a variety of human diseases including, infectious diseases, cancer and other human genetic targets. The company complies with the FDA QSR, ISO 13485:2003 and IVDD regulations and guidance. IMDx is headquartered in Massachusetts, the US.
Reasons to Buy
Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.